Age-related epigenetic drift in the pathogenesis of MDS and AML
The myelodysplastic syndrome (MDS) is a clonal hematologic disorder that frequently evolves to acute myeloid leukemia (AML). Its pathogenesis remains unclear, but mutations in epigenetic modifiers are common and the disease often responds to DNA methylation inhibitors. We analyzed DNA methylation in...
Saved in:
Published in | Genome research Vol. 24; no. 4; pp. 580 - 591 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Cold Spring Harbor Laboratory Press
01.04.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1088-9051 1549-5469 1549-5469 |
DOI | 10.1101/gr.157529.113 |
Cover
Summary: | The myelodysplastic syndrome (MDS) is a clonal hematologic disorder that frequently evolves to acute myeloid leukemia (AML). Its pathogenesis remains unclear, but mutations in epigenetic modifiers are common and the disease often responds to DNA methylation inhibitors. We analyzed DNA methylation in the bone marrow and spleen in two mouse models of MDS/AML, the
NUP98-HOXD13
(
NHD13
) mouse and the
RUNX1
mutant mouse model. Methylation array analysis showed an average of 512/3445 (14.9%) genes hypermethylated in
NHD13
MDS, and 331 (9.6%) genes hypermethylated in
RUNX1
MDS. Thirty-two percent of genes in common between the two models (2/3
NHD13
mice and 2/3
RUNX1
mice) were also hypermethylated in at least two of 19 human MDS samples. Detailed analysis of 41 genes in mice showed progressive drift in DNA methylation from young to old normal bone marrow and spleen; to MDS, where we detected accelerated age-related methylation; and finally to AML, which markedly extends DNA methylation abnormalities. Most of these genes showed similar patterns in human MDS and AML. Repeat element hypomethylation was rare in MDS but marked the transition to AML in some cases. Our data show consistency in patterns of aberrant DNA methylation in human and mouse MDS and suggest that epigenetically, MDS displays an accelerated aging phenotype. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1088-9051 1549-5469 1549-5469 |
DOI: | 10.1101/gr.157529.113 |